CN117646011A - Yarrowia lipolytica genetically engineered bacterium for heterologous expression of lipase and application thereof - Google Patents
Yarrowia lipolytica genetically engineered bacterium for heterologous expression of lipase and application thereof Download PDFInfo
- Publication number
- CN117646011A CN117646011A CN202211080978.4A CN202211080978A CN117646011A CN 117646011 A CN117646011 A CN 117646011A CN 202211080978 A CN202211080978 A CN 202211080978A CN 117646011 A CN117646011 A CN 117646011A
- Authority
- CN
- China
- Prior art keywords
- yarrowia lipolytica
- lipase
- genetically engineered
- liprs
- engineered bacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090001060 Lipase Proteins 0.000 title claims abstract description 49
- 241000894006 Bacteria Species 0.000 title claims abstract description 41
- 239000004367 Lipase Substances 0.000 title claims abstract description 38
- 102000004882 Lipase Human genes 0.000 title claims abstract description 38
- 241000235015 Yarrowia lipolytica Species 0.000 title claims abstract description 38
- 235000019421 lipase Nutrition 0.000 title claims abstract description 38
- 230000014509 gene expression Effects 0.000 title abstract description 7
- 239000013612 plasmid Substances 0.000 claims abstract description 23
- 101150077374 lipR gene Proteins 0.000 claims abstract description 22
- 239000004519 grease Substances 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 230000015556 catabolic process Effects 0.000 claims description 21
- 238000006731 degradation reaction Methods 0.000 claims description 21
- 239000002351 wastewater Substances 0.000 claims description 20
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 238000003259 recombinant expression Methods 0.000 claims description 12
- 239000013604 expression vector Substances 0.000 claims description 11
- 239000002609 medium Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 10
- 239000007222 ypd medium Substances 0.000 claims description 7
- 150000002632 lipids Chemical class 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 230000002950 deficient Effects 0.000 claims description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 3
- 229960000723 ampicillin Drugs 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000002463 transducing effect Effects 0.000 claims description 2
- 238000010353 genetic engineering Methods 0.000 abstract description 6
- 238000002703 mutagenesis Methods 0.000 abstract description 3
- 231100000350 mutagenesis Toxicity 0.000 abstract description 3
- 239000013600 plasmid vector Substances 0.000 abstract description 3
- 238000004065 wastewater treatment Methods 0.000 abstract description 3
- 239000003921 oil Substances 0.000 description 34
- 235000019198 oils Nutrition 0.000 description 34
- 239000000243 solution Substances 0.000 description 13
- 239000013598 vector Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 235000019626 lipase activity Nutrition 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 6
- 238000004448 titration Methods 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 102000004157 Hydrolases Human genes 0.000 description 4
- 108090000604 Hydrolases Proteins 0.000 description 4
- 235000019484 Rapeseed oil Nutrition 0.000 description 4
- 241000235527 Rhizopus Species 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 229940043267 rhodamine b Drugs 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 102100036669 Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Human genes 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 125000003745 glyceroyl group Chemical group C(C(O)CO)(=O)* 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 238000001543 one-way ANOVA Methods 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 description 1
- MKPCNMXYTMQZBE-UHFFFAOYSA-N 7h-purin-6-amine;sulfuric acid;dihydrate Chemical compound O.O.OS(O)(=O)=O.NC1=NC=NC2=C1NC=N2.NC1=NC=NC2=C1NC=N2 MKPCNMXYTMQZBE-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 206010017472 Fumbling Diseases 0.000 description 1
- 101001072574 Homo sapiens Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Proteins 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 101150021155 LIP2 gene Proteins 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000303962 Rhizopus delemar Species 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 101150087371 gpd1 gene Proteins 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XGFJCRNRWOXGQM-UHFFFAOYSA-N hot-2 Chemical compound CCSC1=CC(OC)=C(CCNO)C=C1OC XGFJCRNRWOXGQM-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000002957 persistent organic pollutant Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 108010079522 solysime Proteins 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Hydrology & Water Resources (AREA)
- Botany (AREA)
- Water Supply & Treatment (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Environmental & Geological Engineering (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a yarrowia lipolytica genetically engineered bacterium for heterologous expression of lipase and application thereof. Specifically, a lipase gene lipRs is disclosed, and the nucleotide sequence of the lipRs is shown as SEQ ID NO. 2. The invention obtains the yarrowia lipolytica genetic engineering strain by transferring the recombinant plasmid into the wild yarrowia lipolytica strain, which expresses lipase by a plasmid vector, and has stronger stability compared with mutagenesis; the recombinant plasmid can be transferred into any strain with stronger lipase production capability, and has stronger expansibility and applicability. The yarrowia lipolytica genetic engineering bacterium provided by the invention has important significance on the application of yarrowia lipolytica in grease wastewater treatment.
Description
Technical Field
The invention belongs to the technical field of genetic engineering biology, and particularly relates to a yarrowia lipolytica genetic engineering strain capable of heterologously expressing lipase and application thereof.
Background
Lipase (Lipase, EC3.1.1.3, glyceroyl hydrolase) belongs to the family of carboxyester hydrolases, catalyzing long chains (. Gtoreq.C) 10 ) Hydrolysis of triglycerides. The glyceroyl hydrolase is characterized in that the hydrolysis reaction catalyzed by the glyceroyl hydrolase is a heterogeneous system, and the water-soluble enzyme catalyzes the substrate to react on the interface of the water-insoluble substrate and water, but does not catalyze the water-soluble substrate. In high concentrations of oily wastewater, lipases degrade oils into fatty acids and glycerol, which have wide application in oily wastewater pretreatment, but they are generally soluble and unstable.
In the studies reported so far, it was found that several tens of microorganisms from different sources contain lipase genes, such as Candida sp, rhizopus sp, penicillium sp, pseudomonas sp, etc. Yarrowia lipolytica (Yarrowia lipolytica) is an effective microorganism for treating oily wastewater, is capable of surviving in oily wastewater for a long period of time, and is recognized as a safe class microorganism. Yarrowia lipolytica can be added directly to activated sludge for oily wastewater treatment and become a microbial population in the activated sludge. However, the endogenous lipase secreted by yarrowia lipolytica is too low in activity to effectively degrade the oil. How to increase the yield of yarrowia lipolytica lipase has become a hotspot in current research.
Existing research methods are broadly divided into two types. The first is genetic engineering. The heterologous lipase genes are synthesized into plasmids by metabolic engineering and synthetic biology technology, and then transferred into yarrowia lipolytica for over-expression or the genome of the yarrowia lipolytica is directly modified to improve the lipase expression quantity. For example, as disclosed in Chinese patent document CN108517329A, by establishing the expression of yarrowia lipolytica lipase lip2 in bacillus subtilis WB800N, the efficient production of lipase for feed is realized, and the yield of recombinant lipase is verified to be 109.3U/mL; destin et al have used a mutation to increase the enzyme productivity of yarrowia lipolytica by approximately 30-fold. The second is culture environment optimization. Gerardo et al found that yarrowia lipolytica increased lipase production by using olive oil or corn oil as the carbon source and inducer, adding Tween 80 to the medium, and reducing aeration.
Studies on the lipRs lipase gene are relatively mature. Rhizopus is the main producer of microbial lipase. Nowadays, more than 30 rhizopus lipases are commercially produced, and most rhizopus lipases have the advantages of good stability, high conversion efficiency and the like. In 2007 Zhang Yinbo et al, a high-yield lipase strain, namely Rhizopus delemar YF6, was studied and identified, and a novel lipase gene lipRs (GenBank: DQ 139862) was cloned, and the characteristics of the lipase gene lipRs are suitable for the treatment of oily wastewater. However, the concentration of oily wastewater is generally high, and the strain with good degradation effect on the wastewater with high concentration (such as 100 g/L) of grease is still lacking in the market at present.
The shortcomings of the culture environment optimization means are very remarkable. Time consuming, laborious, requiring extensive prior conditioning fumbling. In addition, the transfer from laboratory pilot test to pilot test requires a condition search again, which additionally increases reagent cost and is costly. The strain obtained by ultraviolet mutagenesis has the remarkable characteristic of instability, and along with the increase of passage number, the genome can generate self-repair to cause mutation failure. Recombinant plasmids are relatively stable in strain state, but currently there are few commercially available lipases that are mature in the market, and require scientific researchers to search for the optimal lipase sequence again and to perform stability identification. The commercial lipase with strong stability and high conversion efficiency cannot be rapidly formed.
Therefore, the search for a fast and simple method for efficiently preparing lipase is of great significance to the application of yarrowia lipolytica in grease wastewater treatment.
Disclosure of Invention
The invention provides a yarrowia lipolytica genetically engineered bacterium for heterologously expressing lipase and application thereof, in order to overcome the defect that high-concentration grease wastewater cannot be treated efficiently
In order to solve the technical problems of the prior art, the first aspect of the invention provides a lipase gene lipRs, wherein the nucleotide sequence of the lipRs is shown as SEQ ID NO. 2.
In a second aspect, the invention provides a recombinant expression vector comprising a lipase gene lipRs according to the first aspect of the invention.
In certain embodiments, one or more of a promoter lac, a resistance gene such as the ampicillin gene Amp, and an auxotroph gene, preferably a leucine auxotroph gene such as leu 2; the skeleton plasmid of the recombinant expression vector is pCAS1yl.
The third aspect of the invention provides a genetically engineered bacterium comprising a recombinant expression vector according to the second aspect of the invention. Preferably, the chassis bacteria of the genetically engineered bacteria are yarrowia lipolytica strains. More preferably, the chassis fungus is yarrowia lipolytica strain ATCC 90811.
According to a fourth aspect of the present invention, there is provided a method for preparing a genetically engineered bacterium according to the third aspect of the present invention, comprising transducing a recombinant expression vector according to the second aspect of the present invention into a yeast such as yarrowia lipolytica. Preferably, the yarrowia lipolytica is yarrowia lipolytica strain ATCC 90811.
In certain embodiments, the yarrowia lipolytica is cultured on a leucine-deficient solid medium.
The leucine-deficient solid medium described above may be an SD-LEU medium as conventionally defined in the art. The main components can be yeast nitrogen source foundation (YNB), glucose, adenine sulfate, L-arginine hydrochloride, L-aspartic acid, L-glutamic acid, L-lysine, L-methionine, L-phenylalanine, L-serine, L-threonine, L-tryptophan, L-tyrosine, L-valine, and uracil.
In a fifth aspect, the present invention provides a method for producing a lipase by fermenting a genetically engineered bacterium according to the third aspect of the present invention.
In a sixth aspect, the present invention provides a method for treating wastewater containing high-concentration grease, comprising mixing the genetically engineered bacterium according to the third aspect of the present invention with the wastewater to degrade the high-concentration grease in the wastewater.
The waste water can be living waste water or industrial waste water, and can comprise kitchen grease waste water and harmful organic pollutant waste water.
In certain embodiments, the genetically engineered bacterium according to the third aspect of the invention is cultured in an oil-containing sugarless YPD medium.
Preferably, the sugarless YPD medium has an oil content of 100g/L.
The formula of the sugarless YPD medium is as follows: 2% peptone, 1% yeast extract, said% being mass to volume ratio.
More preferably, the temperature of the cultivation is 25-32 ℃, e.g. 28 ℃, and/or,
the duration of the incubation is 40-80 hours, for example 60 hours, and/or,
the cultivation is carried out in shaking at a rotational speed of 180-300rpm, for example 200rpm.
The seventh aspect of the invention provides an application of the recombinant expression vector according to the second aspect of the invention or the genetically engineered bacterium according to the third aspect of the invention in grease degradation.
On the basis of conforming to the common knowledge in the field, the above preferred conditions can be arbitrarily combined to obtain the preferred examples of the invention.
The reagents and materials used in the present invention are commercially available.
The invention has the positive progress effects that:
compared with the method of unsteady expression of mutagenesis, the expression of lipase by plasmid vector has strong stability; the recombinant plasmid can be transferred into any strain with stronger lipase production capacity, and has strong expansibility; the lipRs lipase gene has the potential of strong stability and commercial application and strong applicability. Compared with the method for optimizing the culture environment, the method has the advantages of short treatment time and no need of adding additional reagent cost.
Drawings
FIG. 1 shows a recombinant vector LipRs_pCAS1yl containing a lipRs gene fragment, full length 7714bp.
FIG. 2 is an agarose gel electrophoresis image of recombinant vector LipRs_pCAS1yl.
FIG. 3 shows the results of coating leucine auxotroph medium (SD-LEU) on yeast cells transformed with LipRs_pCAS1yl recombinant vector using a yeast transformation package.
FIG. 4 shows the results of gel electrophoresis PCR amplification using the yeast plasmid extraction kit.
FIG. 5 shows the results of coating on leucine auxotrophic medium (SD-LEU) after 3 passages of yarrowia lipolytica into recombinant vectors.
FIG. 6 shows the residual oil content of the centrifuge tube after lipid degradation of experimental bacteria and genetically engineered bacteria (3 single clones are selected and two replicates per group).
FIG. 7 is a comparison of the production of hydrolytic circles by yarrowia lipolytica ATCC90811 and ATCC90811-lipRS genetically engineered bacteria on rhodamine plates; A. b is a wild strain; C. d is genetically engineered bacteria.
Fig. 8 shows the residual oil amount of the centrifuge tube after the oil degradation of the experimental bacteria and the genetically engineered bacteria GPD 1.
Detailed Description
The invention is further illustrated by means of the following examples, which are not intended to limit the scope of the invention. The experimental methods, in which specific conditions are not noted in the following examples, were selected according to conventional methods and conditions, or according to the commercial specifications.
Example 1 plasmid System construction
The recombinant vector LipRs_pCAS1yl is obtained by using yarrowia lipolytica plasmid pCAS1yl as a vector and connecting the in vitro synthesized lipRs gene fragment to the vector. lipRs gene synthesis was performed by the company gold sri biotechnology. The synthesis length of the lipRs gene is 1179bp (shown as SEQ ID NO: 2). The genetic constitution of the plasmid is shown in FIG. 1, and the recombinant vector structure comprises the following gene fragments: the promoter lac, the lipase gene lipRs, the resistance gene ampicillin gene Amp and the leucine auxotroph gene leu2.
Original sequence (SEQ ID NO: 1)
ATGGTTTCATTCATTTCCATTACTCAAGGTGTAAGTCTTTGTCTTCTTGTCTCTTCCATGATGATGGGCTCTTCTGCTGTTCCCGTTTCTGGTAAAACTGGGGCTTCAAGTGATGCTGTATCCACATCTGGCAACTTTACTCTCCCTCCTATCATCTCTAGTCGTTGTGCGCCTCCTTCTGGAAAAGGATCCAGCAGCGATCTTCAATCCGAGCCTTACTTTGTCAAGAAAAACACCGAATGGTACACTGCCCATGGTGGAGATCTGGCTGCCATTGGTAAACGTGACGATAATCAAGTCGGTGGCATGACATTGGATTTACCCGAAAATGCTCCTCCTATCGCAAGCTCTTATTCCCTCGACAGTGTCTCTGATAGCTCAGTCGTTGCTGCTACTGCCGCTCAAGTTCAAGAGCTTACCAAGTATGCTGGTGTCGCCGCCACTGCCTATTGTCGTAGTGTTGTTCCTGGAAACAAATGGGACTGCAAGCAATGTTTGAAGTGGGTTCCTGATGGTAAAATTATCACAACATTCACTTCTATTCTCTCAGACACAAATGGTTATGTCTTAAGAAGTGATAAGCAGAAGACTATCTATCTTGTTTTTCGTGGTACCAACTCCTTCAGAAGTGCTATCACAGACATCGTCTTCAATTTCTCAAATTATAAGCCTGTTTCTGGTGCCAAGGTACACACTGGCTTCCTCTCTTCTTACGAACAAGTCGTCAATGATTACTTCCCTGTTATCCAAGCCCAGTTAACAGCCAATCCTAGCTACCAAGTTATTGTTACTGGTCACTCACTTGGTGGAGCCCAAGCTTTGCTTGCTGGTATGGACTTATACCAACGCGAAAAGAGACTGTCTCCCAAGAACTTGAGTATTTTCACCATCGGTGGTCCTCGTGTCGAAAACCCTACCTTTGCTTACTATGTTGAATCTACTGGTATTCCTTTTCATCGTACTGTCCACAAGAGAGATATCGTCCCTCACGTCCCCCCTCAAGCAATGGGATTCCTTCATCCTGGTGTTGAGTCTTGGATCAAGTCTGGTGATTCTAATGTTCAAATCTGTAACTCTCAAATCGAGACCAAGGCTTGTAGTAACTCAATCGTTCCTTTCACTTCTATTGCTGACCACTTGTCTTACTTTGGTATCAACGAAGGAAGCTGTTTGTAATGA
Codon optimized sequence (SEQ ID NO: 2)
ATGGTGTCGTTCATTTCTATTACCCAAGGCGTGTCTCTCTGTCTCCTCGTCAGCTCCATGATGATGGGCTCTTCCGCTGTTCCTGTATCTGGAAAGACTGGTGCTTCCTCGGATGCAGTCTCAACGTCAGGCAACTTTACGCTACCACCCATTATCAGTAGTCGATGCGCGCCGCCTTCGGGCAAAGGTTCCAGTTCGGACCTGCAGTCCGAGCCTTACTTTGTCAAGAAGAACACCGAGTGGTACACCGCACATGGCGGAGATCTGGCCGCCATTGGAAAACGGGACGACAACCAGGTTGGAGGAATGACCCTGGATCTCCCCGAAAATGCTCCTCCTATTGCGTCATCATATTCGCTTGACTCCGTCTCTGATTCTTCGGTGGTGGCCGCGACAGCTGCTCAGGTCCAGGAGCTCACTAAGTACGCCGGCGTTGCTGCCACTGCCTACTGCCGTTCGGTGGTTCCCGGAAACAAGTGGGACTGCAAGCAATGTTTGAAATGGGTGCCCGATGGCAAGATCATCACTACCTTTACAAGCATTCTTAGCGACACCAACGGCTACGTCTTGCGCTCCGACAAGCAGAAGACCATCTACCTGGTTTTCCGAGGTACAAACTCTTTCAGATCTGCTATCACCGATATTGTCTTCAACTTCTCCAACTACAAGCCCGTTTCGGGTGCCAAAGTGCACACGGGTTTCCTGTCATCCTACGAGCAGGTGGTCAACGACTACTTCCCCGTCATCCAGGCACAACTGACAGCCAACCCTTCTTATCAAGTTATCGTGACTGGTCACAGCCTGGGAGGCGCCCAGGCACTTCTTGCTGGCATGGACCTCTACCAGCGAGAGAAGCGGCTGTCTCCCAAGAATCTGAGCATCTTCACTATAGGGGGCCCCCGAGTGGAGAACCCCACCTTCGCTTACTACGTCGAATCGACTGGAATCCCCTTCCACAGAACGGTCCACAAGCGAGACATTGTGCCTCATGTGCCACCACAGGCCATGGGTTTTCTGCATCCTGGTGTCGAGTCGTGGATCAAGTCTGGAGACTCTAATGTGCAGATCTGCAACTCCCAGATTGAGACCAAGGCCTGTTCCAATTCTATTGTTCCGTTTACCTCCATTGCCGACCACTTGTCTTATTTTGGCATCAACGAAGGATCCTGTTTATGATGA
Example 2 plasmid transformed E.coli DH 5. Alpha. Bacteria protection and screening
100ng of the recombinant vector synthesized in example 1 was added to 100. Mu.L of E.coli DH 5. Alpha. Competent cells, gently flicked and mixed, placed on ice for 30min, heat-shocked for 45s at 42℃for 2min on ice, added with 700. Mu.L of LB liquid medium, shaken for 1h at 37℃and centrifuged, suspended with 100. Mu.L of supernatant, and then spread on Amp plates (Amp final concentration 50. Mu.g/mL); the transformants grown on the plates were then subjected to plasmid gel running verification as shown in FIG. 2. The results showed that the lipRs gene fragment was successfully ligated to the plasmid vector, and the transformant strain was simultaneously subjected to bacterial protection.
Example 3 Yeast transformation, plasmid extraction and validation
The recombinant vector LipRs_pCAS1yl in the above transformant was extracted, and the plasmid in the transformant was transformed into a chassis strain (yarrowia lipolytica ATCC90811, available from Ningbo Minnean BioCo., ltd.) using a yeast transformation package (Frozen-EZ Yeast Transformation kit). Yeast seed solution was spread on leucine-deficient solid medium (SD-LEU), cultured at 28℃for 48 hours, and colony growth was observed, as shown in FIG. 3.
To further verify the transfer of the plasmid, the present invention performed PCR amplification of specific fragments on the proposed plasmid. The results of gel electrophoresis are shown in FIG. 4, and the gel is cut, purified and sequenced. The plasmid transfer was confirmed to be successful. After transferring into yeast, extracting, the nucleotide sequence of plasmid is shown as SEQ ID NO. 3 and SEQ ID NO. 4.
Plasmid lipRs M13F (SEQ ID NO: 3)
AGGCCGGTACGCTTTTCGTAGATAATGGAATACAAATGGATATCCAGAGTATACACATGGATAGTATACACTGACACGACAATTCTGTATCTCTTTATGTTAACTACTGTGAGGCGTTAAATAGAGCTTGATATATAAAATGTTACATTTCACAGTCTGAACTTTTGCAGATTACCTAATTTGGTAAGATATTAATTATGAACTGAAAGTTGATGGCATCCCTAAATTTGATGAAAGGGGGATCACGCGTCTGTACAGAAAAAAAAGAAAAATTTGAAATATAAATAACGTTCTTAATACTAACATAACTATAAAAAAATAAATAGGGACCTAGACTTCAGGTTGTCTAACTCCTTCCTTTTCGGTTAGAGCGGATGTGGGGGGAGGGCGTGAATGTAAGCGTGACATAACTAATTACATGACTCGAGGTCCAATGACTCGAGGTCCAAAATCATCATAAACAGGATCCTTCGTTGATGCCAAAATAAGACAAGTGGTCGGCAATGGAGGTAAACGGAACAATAGAATTGGAACAGGCCTTGGTCTCAATCTGGGAGTTGCAGATCTGCACATTAGAGTCTCCAGACTTGATCCACGACTCGACACCAGGATGCAGAAAACCCATGGCCTGTGGTGGCACATGAGGCACAATGTCTCGCTTGTGGACCGTTCTGTGGAAGGGGATTCCAGTCGATTCGACGTAGTAAGCGAAGGTGGGGTTCTCCACTCGGGGGCCCCCTATAGTGAAGATGCTCAGATTCTTGGGAGACAGCCGCTTCTCTCGCTGGTAGAGGTCCATGCCAGCAAGAAGTGCCTGGGCGCCTCCCAGGCTGTGACCAGTCACGATAACTTGATAAGAAAGGTTGGCTGTCAGTTGTGCCTGGATGACGGGGAAGTAGTCGTTGACCACCTGCTCGTAGATGACAGGAAACCGTGTGCACTTTGGCACCCGAAACGGGCTTGTAGTTGGAAGAGTTGAAGACAATATCGTGATAGCAGATCTGAAAGGAGTTTGTACCTCGGAAACAAGGTAGATGTCTCTGCTGTCGAGCGCAGACGTAGCGTGTTGTCGCTAGATGCTGTAAGTATGATGATCTTGCCATCGGCACCAATTCAACATTGCTGAGTCACCTTGTTGCGGAGCATCGAACGTAGTA
Plasmid lipRs M13R (SEQ ID NO: 4)
CTCATGATTGTTTAACAGAGACCGGGTTGGCGGCGTATTTGTGTCCCAAAAAACAGCCCCAATTGCCCCAATTGACCCCAAATTGACCCAGTAGCGGGCCCAACCCCGGCGAGAGCCCCCTTCACCCCACATATCAAACCTCCCCCGGTTCCCACACTTGCCGTTAAGGGCGTAGGGTACTGCAGTCTGGAATCTACGCTTGTTCAGACTTTGTACTAGTTTCTTTGTCTGGCCATCCGGGTAACCCATGCCGGACGCAAAATAGACTACTGAAAATTTTTTTGCTTTGTGGTTGGGACTTTAGCCAAGGGTATAAAAGACCACCGTCCCCGAATTACCTTTCCTCTTCTTTTCTCTCTCTCCTTGTCAACTCACACCCGAAATCGTTAAGCATTTCCTTCTGAGTATAAGAATCATTCAAAATGGTGAGTTTCAGAGGCAGCAGCAATTGCCACGGGCTTTGAGCACACGGCCGGGTGTGGTCCCATTCCCATCGACACAAGACGCCACGTCATCCGACCAGCACTTTTTGCAGTACTAACCGCAGATGGTGTCGTTCATTTCTATTACCCAAGGCGTGTCTCTCTGTCTCCTCGTCAGCTCCATGATGATGGGCTCTTCCGCTGTTCCTGTATCTGGAAAGACTGGTGCTTCCTCGGATGCAGTCTCAACGTCAGGCAACTTTACGCTACCACCCATTATCAGTAGTCGATGCGCGCCGCCTTCGGGCAAAGGTTCCAGTTCGGACCTGCAGTCCGAGCCTTACTTTGTCAAGAAGAACACCGAGTGGTACACCGCACATGGCGGAGATCTGGCCGCCATTGGAAAACGGGACGACAACCAGGTTGGAGGAATGACCCTGGATCTCCCCGAAAATGCTCCTCCTATTGCGTCATCATATTCGCTTGACTCCGTCTCTGATTCTTCGGTGGTGGCCGCGACAGCTGCTCAAGTCCAGGAGCTCACTACGTACGCCGGCGTTGCTGCACTGCCTACTGCCGTTCGGTGGTCCCGAACAGTGGGACTGCCAGCATGTTTGAACTGGTGCACGATGGCAGATCATCACTACTTTACAGCATCTAGCGACCCACCGCTACGTCTGCGCTCGACAGCAAAGACATCTACCTGGTTTCGAGGTCACTCT
EXAMPLE 4 identification of Lipase by rhodamine B plate
100mL of YPD medium (containing 1.5% agar) was placed in a flask, and sterilized at 121℃for 20min. Rapeseed oil emulsion was prepared with 25% triton-X100 solution in PBS buffer (ph=7.4) for use. A25% Triton-X100 solution was diluted to 5% with PBS buffer (pH=7.4), 20mL of an emulsion containing 40% (V/V) rapeseed oil was prepared, and the mixture was sonicated in an ice bath on a cell disruptor for 10min (50%, 2 s). And storing at 4 ℃ after the emulsification is completed. After sterilizing the above-mentioned Erlenmeyer flasks, 250. Mu.L of 1M MgCl was added to each Erlenmeyer flask while it was hot 2 ,125μL 1M CaCl 2 And 250. Mu.L of 20% dextrose solution, incubated at 60 ℃. 100mL of the oil emulsion and rhodamine B solution (5 mg/mL, final concentration 0.001%) were added to different Erlenmeyer flasks, and 1.5% agar was added, and incubated at 60℃for 10min to prepare rhodamine B plates, which were stored at 4 ℃. Diluting the bacterial liquid obtained by culturing the bacterial body transferred into the recombinant vector by 100 times, and OD 600 The value is 0.1-0.3, and 100 μl is coated on rhodamine B plate culture medium. The transparent ring size was observed by incubation at 28℃for 96 h.
The invention further verifies the capability of generating lipase by identifying the size of the hydrolysis circle generated by rhodamine plate culture medium. Compared with the wild strain, the genetically engineered bacterium generates more remarkable lipase hydrolysis circle in 48 hours, which means that the genetically engineered bacterium has stronger lipase generating capacity than the wild strain (as shown in figure 7).
Example 5 measurement of degradation Rate of oil
And (3) carrying out a grease degradation test by using high-concentration oily wastewater (oil content of 100 g/L). The oil degradation rate is quantitatively measured by adopting a centrifugal volumetric method. 10mL of rapeseed oil, 2mL of bacterial liquid and 88mL of sugar-free YPD (peptone 20g/L, yeast extract 10 g/L) liquid medium are added into each conical flask, and the mixture is placed on a shaking table for shake culture at 28 ℃ at 200rpm for 60 hours. After the cultivation is finished, the conical flask is taken out of the shaking table, the solution in the conical flask is evenly shaken and transferred into two 50mL centrifuge tubes, and the solution is centrifuged at a low speed of 4000rpm for 10min. At this time, the 50mL centrifuge tube is divided into four layers, the uppermost layer is an oil layer in a clear oil state, the second layer is an emulsion state of an oil degradation product layer, the third layer is a light brown liquid state of a fungus liquid layer, and the bottommost layer is a fungus layer in a flocculent state. The uppermost layer of oil in the centrifuge tube was transferred to a 15mL measuring centrifuge tube using a pipette gun, and the second layer of solution was transferred to a plurality of 2mL centrifuge tubes. All 2mL centrifuge tubes were high speed centrifuged at 12000rpm for 5min. At this time, the 2mL centrifuge tube is divided into three layers, the uppermost layer is an oil layer which is in a clear oil state, the second layer is an oil degradation product layer which is in a compact solid state, and the third layer is a fungus liquid layer which is in a light brown liquid state. The uppermost layer of oil in the 2mL centrifuge tube was transferred to the corresponding measuring centrifuge tube. All remaining oil that was not degraded (to the nearest 0.1 mL) was collected in the measurement centrifuge tube. At this time, we define the lipid degradation rate of yeast to be κ, and the calculation method is shown in formula (1.1):
wherein V is 0 Initial refueling volume (mL); v (V) 1 Remaining volume (mL) of oil for control group; v (V) 2 Residual volume (mL) for experimental group oil.
EXAMPLE 6 plasmid stability test of Strain
The stability of the chassis strain (yarrowia lipolytica ATCC 90811) against the copy number of the recombinant vector pCAS1yl-lipRs was further verified by multiple passages and replications. After multiple generations of replication and passaging, the yeast cells transformed into the recombinant vector were screened again using leucine auxotroph medium (SD-LEU), and the results are shown in FIG. 5. It can be seen that the stability of the strain plasmid after multiple replications and passages is good.
Effect example 1:
wild bacteria (No. ATCC 90811) and genetically engineered bacteria (No. ATCC 90811-lipRs) were added to 100mL of sugar-free YPD medium (peptone 20g/L, yeast extract 10 g/L) containing 100g/L of rapeseed oil in an inoculum size of 2% (V/V), and the mixture was sealed with a sterile sealing film, placed in an air-bath thermostatic shaker, and cultured at 28℃at 200rpm for 60 hours; after the cultivation is finished, the conical flask is taken out of the shaking table, the solution is transferred into two 50mL centrifuge tubes in a shaking mode, the solution is centrifuged at a low speed of 4000rpm for 10min, and the uppermost oil layer in the centrifuge tubes is transferred into a 15mL measuring centrifuge tube by using a pipette. The second layer of solution was then transferred to a plurality of 2mL centrifuge tubes, all 2mL centrifuge tubes were high speed centrifuged at 12000rpm for 5min, and the uppermost layer of oil in the 2mL centrifuge tubes was transferred to the corresponding 15mL measuring centrifuge tube. The graduations are finally measured and recorded as shown in fig. 6. And the oil degradation rate was calculated, and the measurement results are shown in table 1. The results show that the oil degradation rate of the wild bacteria is 20% +/-1%, the oil degradation rate of the genetically engineered bacteria is 30% -34%, and the average oil degradation rate is 31.7% +/-1.7%. The recombinant expression of the heterologous lipase gene lipRs can improve the grease degradation capability of the yeast strain by more than 1.7 times. According to one-way anova, the lipid degradation rates of the genetically engineered bacterial group (accession number: ATCC 90811-lipRs) were significantly statistically different from that of the wild bacterial group (accession number: ATCC 90811), with p < 0.01, as shown in Table 2.
Table 1 test strain and determination of lipid degradation rate of genetically engineered bacteria
TABLE 2 one-way analysis of variance for ATCC90811-lipRS strains and wild-type groups
| Analysis of variance | ||||||
| Source of discrepancy | SS | df | MS | F | P-value | F crit |
| Inter-group | 408.3333 | 1 | 408.3333 | 115.566 | 8.1597E-07 | 4.964603 |
| Within a group | 35.33333 | 10 | 3.533333 | |||
| Totals to | 443.6667 | 11 |
Effect example 2 verification of Lipase Activity of wild strain and genetically engineered liquid
And (3) performing lipase activity measurement on the bacterial liquid supernatant by a reference titration method, and further identifying the lipolytic capability of the genetically engineered bacteria. Lipase ability is expressed in terms of lipase activity, i.e., the amount of lipase required to decompose olive oil to produce 1. Mu. Mol of free lipase acid per minute at 40℃in 0.025mol/L PBS buffer (pH 7.5)The enzyme amount is one lipase activity, and the unit is U/mL. The results showed that after 48h of cultivation of yarrowia lipolytica ATCC90811 (OD 600 When the total amount of the lipase is approximately equal to 1), the lipase activity of the seed solution is 7.75U/mL by using a reference titration method, and the lipase activity of the genetically engineered bacterium is 9.5U/mL, which is improved by 22.7%.
The lipase activity of the seed solution was measured by the reference titration method as follows: mixing 4mL of a substrate with 5mL of phosphate buffer solution by taking polyvinyl alcohol olive oil emulsion as a substrate, preheating in a water bath at 40 ℃ for 5min, adding 1mL of supernatant obtained by centrifuging after strain fermentation to form a 10mL reaction system, and heating in a water bath at 40 ℃. The reaction was allowed to proceed for 15min at 200rpm on a shaker, and then quenched by the addition of 10mL of 95% ethanol. The fatty acid amount of the catalytic hydrolysis of lipase is measured by dripping 0.1mol/L sodium hydroxide standard solution, 3 drops of L% phenolphthalein are added as an indicator, the liquid is dripped to be light pink, the 3s is kept unchanged, namely, the titration end point is obtained, the consumption of sodium hydroxide is recorded, and the enzyme activity is calculated by comparing with a control sample. The control sample was not added with fermentation broth, and the other samples were identical, and the measurement was repeated 3 times. The calculation formula of lipase activity is: x= (B-ase:Sub>A) ×5×n. Wherein X represents lipase activity of the sample, and the unit is U/mL; b is the amount of NaOH standard solution required by titration of a sample group, and the unit is mL; a is the amount of NaOH standard solution required by the completion of titration of a blank group, and the unit is mL; n is the dilution multiple of the enzyme solution to be tested in the experiment.
Comparative example
The present invention contemplates other enzymes, such as glycerol-3-phosphate dehydrogenase (encoded by GPD1, also a key enzyme in the glycerol metabolic pathway). The results of the oil degradation are shown in fig. 8 and table 3 below. The results showed that the average oil degradation rate of the genetically engineered bacterium (No. ATCC90811-gpd 1) into which the glycerol-3-phosphate dehydrogenase was transferred was about 31%, which is also significantly different from that of the wild-type bacterium group, and p=0.017, as shown in Table 4 (oil degradation conditions are the same as the present invention, the oil content of the high-concentration oil waste water is 100g/L, the inoculum size is 2%, and the inoculum size is 200rpm at 28 ℃ C., 60 h). The highest oil degradation rate of the genetically engineered bacterium (number: ATCC 90811-lipRs) reaches 34% under the same condition. In comparison, the genetic engineering of lipRs lipase is more advantageous.
TABLE 3 determination of lipid degradation Rate of experimental strains and genetically engineered bacteria
TABLE 4 one-way analysis of variance for ATCC90811-gpd1 Strain and wild type group
| Analysis of variance | ||||||
| Source of discrepancy | SS | df | MS | F | P-value | F crit |
| Inter-group | 182.25 | 1 | 182.25 | 56.07692 | 0.017369 | 18.51282 |
| Within a group | 6.5 | 2 | 3.25 | |||
| Totals to | 188.75 | 3 |
Claims (10)
1. A lipase gene lipRs is characterized in that the nucleotide sequence of the lipRs is shown in SEQ ID NO. 2.
2. A recombinant expression vector comprising the lipase gene lipRs of claim 1.
3. Recombinant expression vector according to claim 2, characterized in that it further comprises one or more of a promoter lac, a resistance gene such as the ampicillin gene Amp and an auxotroph gene, preferably a leucine auxotroph gene such as leu 2; the skeleton plasmid of the recombinant expression vector is pCAS1yl.
4. A genetically engineered bacterium comprising the recombinant expression vector of claim 2 or 3; preferably, the chassis bacteria of the genetically engineered bacteria are yarrowia lipolytica strains; more preferably, the chassis fungus is yarrowia lipolytica strain ATCC 90811.
5. A method for producing the genetically engineered bacterium of claim 4, comprising transducing the recombinant expression vector of claim 2 or 3 into yarrowia lipolytica; preferably, the yarrowia lipolytica is yarrowia lipolytica strain ATCC 90811.
6. The method of claim 5, wherein the yarrowia lipolytica is cultured on a leucine-deficient solid medium.
7. A method for producing a lipase, which comprises fermenting the genetically engineered bacterium according to claim 4.
8. A method for treating wastewater containing high-concentration grease, comprising mixing the genetically engineered bacterium according to claim 4 with the wastewater to degrade the high-concentration grease in the wastewater.
9. The method according to claim 8, wherein the genetically engineered bacterium according to claim 4 is cultured in an oil-containing sugarless YPD medium;
preferably, the oil content of the sugarless YPD medium is 100g/L;
more preferably, the temperature of the cultivation is 25-32 ℃, e.g. 28 ℃, and/or,
the duration of the incubation is 40-80 hours, for example 60 hours, and/or,
the cultivation is carried out in shaking at a rotational speed of 180-300rpm, for example 200rpm.
10. Use of the recombinant expression vector of claim 2 or 3 or the genetically engineered bacterium of claim 4 in lipid degradation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211080978.4A CN117646011A (en) | 2022-09-05 | 2022-09-05 | Yarrowia lipolytica genetically engineered bacterium for heterologous expression of lipase and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211080978.4A CN117646011A (en) | 2022-09-05 | 2022-09-05 | Yarrowia lipolytica genetically engineered bacterium for heterologous expression of lipase and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117646011A true CN117646011A (en) | 2024-03-05 |
Family
ID=90046572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211080978.4A Pending CN117646011A (en) | 2022-09-05 | 2022-09-05 | Yarrowia lipolytica genetically engineered bacterium for heterologous expression of lipase and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117646011A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120210158A (en) * | 2025-05-29 | 2025-06-27 | 成都圆大生物科技有限公司 | A lipase, encoding gene Lip1.1 and its genetic engineering bacteria and application |
-
2022
- 2022-09-05 CN CN202211080978.4A patent/CN117646011A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120210158A (en) * | 2025-05-29 | 2025-06-27 | 成都圆大生物科技有限公司 | A lipase, encoding gene Lip1.1 and its genetic engineering bacteria and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ellaiah et al. | Production of lipase by immobilized cells of Aspergillus niger | |
| Christopher et al. | A thermo‐alkaline lipase from a new thermophile Geobacillus thermodenitrificans AV‐5 with potential application in biodiesel production | |
| Benjamin et al. | Coconut cake–a potent substrate for the production of lipase by Candida rugosa in solid‐state fermentation | |
| CN109468241A (en) | Engineered microorganisms and methods for microbial oil production | |
| Boonmahome et al. | Lipase-producing bacterium and its enzyme characterization | |
| CN105121626A (en) | Bacterial strain Rhodococcus etherovorans VKM Ac-2610D producing nitrile hydratase, its culture method and method for producing acrylamide | |
| Li et al. | Screening, purification and characterization of lipase from Burkholderia pyrrocinia B1213 | |
| Demera et al. | Production, extraction and characterization of lipases from the antarctic yeast Guehomyces pullulans | |
| Tang et al. | Biocatalytic preparation of (S)-phenyl glycidyl ether using newly isolated Bacillus megaterium ECU1001 | |
| Baloch et al. | The occurrence of triple catalytic characteristics of yeast lipases and their application prospects in biodiesel production from non-edible Jatropha curcas oil in a solvent-free system | |
| Ma et al. | Cloning, deletion, and overexpression of a glucose oxidase gene in Aureobasidium sp. P6 for Ca2+-gluconic acid overproduction | |
| Ji et al. | Atmospheric and room temperature plasma treatment to improve methanol tolerance and catalytic activity of Mucor circinelloides for one-step biodiesel production | |
| CN117646011A (en) | Yarrowia lipolytica genetically engineered bacterium for heterologous expression of lipase and application thereof | |
| CN102174432B (en) | Organic solvent-resistant high-activity lipase producing strain, gene of produced lipase and application of lipase | |
| Kashiyama et al. | Engineered chlorophyll catabolism conferring predator resistance for microalgal biomass production | |
| Liu et al. | Isolation and identification of a novel Rhodococcus sp. ML-0004 producing epoxide hydrolase and optimization of enzyme production | |
| CN104726477A (en) | Lipase coding gene and engineering strain thereof | |
| Novotný et al. | The production of lipases by some Candida and Yarrowia yeasts | |
| Deive et al. | A comprehensive study of lipase production by Yarrowia lipolytica CECT 1240 (ATCC 18942): from shake flask to continuous bioreactor | |
| CN101506359B (en) | Methods for the production of lipases, transformed Yarrowia lipolytica cells capable of producing said lipases and their uses | |
| CN101918568A (en) | Clostridium sarmentosum for preparing biogas | |
| Gong et al. | Biocatalytic preparation of enantiopure (R)-ketoprofen from its racemic ester by a new yeast isolate Citeromyces matriensis CGMCC 0573 | |
| CA1211728A (en) | Primary and secondary alcohol dehydrogenase enzymes and use thereof | |
| Rahman et al. | Investigation on a Bangladeshi isolate Bacillus aryabhattai for promising biotechnological applications | |
| CN111378583B (en) | Trichoderma reesei and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |